Alessandra Petrolati
Overview
Explore the profile of Alessandra Petrolati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Francica G, Petrolati A, Di Stasio E, Pacella S, Stasi R, Pacella C
AJR Am J Roentgenol
. 2012 Nov;
199(6):1393-401.
PMID: 23169736
Objective: A high-risk location--defined as the tumor margin being less than 5 mm from large vessels or vital structures--represents a well-known limitation and contraindication for radiofrequency ablation of hepatocellular carcinoma...
2.
Petrolati A, Pacella C, Nasoni S, Rossi Z, Altavilla N, Cipolla R, et al.
Am J Gastroenterol
. 2009 Oct;
104(10):2638-9.
PMID: 19806104
No abstract available.
3.
Petrolati A, Altavilla N, Cipolla R, Fenderico P, Forlini G, Nasoni S, et al.
Am J Gastroenterol
. 2009 Mar;
104(4):1058.
PMID: 19259072
No abstract available.
4.
Angelico M, Petrolati A, Lionetti R, Lenci I, Burra P, Donato M, et al.
J Hepatol
. 2007 Mar;
46(6):1009-17.
PMID: 17328985
Background/aims: We performed a randomized trial on pegylated interferon alfa-2a (Peg-IFNalpha) monotherapy vs Peg-IFNalpha and ribavirin in non-cirrhotic liver transplant recipients with recurrent hepatitis C. Methods: Forty-two patients transplanted for...
5.
Pacella C, Bizzarri G, Francica G, Forlini G, Petrolati A, Valle D, et al.
J Hepatol
. 2006 Mar;
44(5):902-9.
PMID: 16545480
Background/aims: The factors which predict the long-term outcome in patients with hepatocellular carcinoma who are treated with percutaneous laser ablation (PLA) are not well established. Methods: We prospectively analyzed treatment...
6.
Angelico M, Di Paolo D, Trinito M, Petrolati A, Araco A, Zazza S, et al.
Hepatology
. 2002 Jan;
35(1):176-81.
PMID: 11786974
Long-term immunoprophylaxis with anti-HBs immunoglobulins (HBIg) is used to prevent hepatitis B (HBV) reinfection after liver transplantation for HBV-related cirrhosis. This approach is highly expensive. A recent report proposed posttransplant...